Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review.

Select Content Type
Clinical Guidelines
Authored By
Weld-Blundell IV, Grech L, Learmonth YC, Marck CH
Authored On
Interests
Neurology
Immunology Allergy & Inflammation
Speciality
Neurology
Immunology Allergy & Inflammation
Book Detail
volume
145
ISSN
1600-0404
Publication Date
Actions
Download in App
Event Data
{"article_title":"Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review.","author":"Weld-Blundell IV, Grech L, Learmonth YC, Marck CH","journal_title":"Acta neurologica Scandinavica","issn":"1600-0404","isbn":"","publication_date":"2022 Apr","volume":"145","issue":"4","first_page":"379","page_count":"","accession_number":"35037722","doi":"10.1111\/ane.13574","publisher":"Wiley-Blackwell","doctype":"Journal Article","subjects":"Complementary Therapies; Multiple Sclerosis therapy; Smoking Cessation; Consensus; Humans; Life Style","interest_area":["Neurology"," Immunology Allergy & Inflammation"],"abstract":"Management of multiple sclerosis (MS) may comprise clinical interventions and self-management strategies, including complementary therapies and modifiable lifestyle factors such as exercise and smoking cessation. Lifestyle modifications and complementary therapies with proven safety and efficacy are essential as part of best-practice MS management, especially when faced with limited access to healthcare services. However, it is unclear to what extent MS clinical practice guidelines and consensus statements address these strategies. A systematic review was conducted, wherein MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus, Web of Science, guideline databases and developer sites were searched for guidelines and consensus statements that addressed lifestyle modifications and complementary therapies of interest. Two researchers independently screened articles, extracted data and assessed guideline quality using the Appraisal of Guidelines for Research and Evaluation version II. Thirty-one guidelines and consensus statements were included. Quality was high for 'clarity of presentation' (77%) and 'scope and purpose' (73%), moderate for 'stakeholder development' (56%), 'rigour of development' (48%) and 'editorial independence' (47%), and low for 'applicability' (29%). Two guidelines, related to physical activity and exercise, mindfulness, smoking cessation, and vitamin D and polyunsaturated fatty acid supplementation, scored high in all domains. These guidelines were two of only four guidelines intended for use by people with MS. High-quality guidelines and consensus statements to guide lifestyle modifications and complementary therapies in MS management are limited. Our findings indicate the need for more guidelines intended for use by people with MS, and a further focus on implementation resources. \ufffd 2022 John Wiley & Sons A\/S. Published by John Wiley & Sons Ltd.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=35037722&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Weld-Blundell IV, Grech L, Learmonth YC, Marck CH","Journal_Info":"Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0404 (Electronic) Linking ISSN: 00016314 NLM ISO Abbreviation: Acta Neurol Scand Subsets: MEDLINE","Publication_Type":"Journal Article; Review; Systematic Review","Published_Date":"2022-04-01","Source":"Acta neurologica Scandinavica [Acta Neurol Scand] 2022 Apr; Vol. 145 (4), pp. 379-392. Date of Electronic Publication: 2022 Jan 17.","Languages":"English","Electronic_ISSN":"1600-0404","MeSH_Terms":"Complementary Therapies* , Multiple Sclerosis*\/therapy , Smoking Cessation*, Consensus ; Humans ; Life Style","Subjects":"Consensus, Humans, Life Style, Complementary Therapies, Multiple Sclerosis therapy, Smoking Cessation","Title_Abbreviations":"Acta neurologica Scandinavica","Volume":"145"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"35037722","RelevancyScore":"877","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"876.798950195313"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35037722&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35037722&authtype=shib&custid=ns346513&group=main&profile=eds"}
ISSN
1600-0404
IS_Ebsco
true
Additional Info
["Weld-Blundell IV, Grech L, Learmonth YC, Marck CH","Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0404 (Electronic) Linking ISSN: 00016314 NLM ISO Abbreviation: Acta Neurol Scand Subsets: MEDLINE","Journal Article; Review; Systematic Review","2022-04-01","Acta neurologica Scandinavica [Acta Neurol Scand] 2022 Apr; Vol. 145 (4), pp. 379-392. Date of Electronic Publication: 2022 Jan 17.","English","1600-0404","Complementary Therapies* , Multiple Sclerosis*\/therapy , Smoking Cessation*, Consensus ; Humans ; Life Style","Consensus, Humans, Life Style, Complementary Therapies, Multiple Sclerosis therapy, Smoking Cessation","Acta neurologica Scandinavica","145"]
Description
Management of multiple sclerosis (MS) may comprise clinical interventions and self-management strategies, including complementary therapies and modifiable lifestyle factors such as exercise and smoking cessation. Lifestyle modifications and complementary therapies with proven safety and efficacy are essential as part of best-practice MS management, especially when faced with limited access to healthcare services. However, it is unclear to what extent MS clinical practice guidelines and consensus statements address these strategies. A systematic review was conducted, wherein MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus, Web of Science, guideline databases and developer sites were searched for guidelines and consensus statements that addressed lifestyle modifications and complementary therapies of interest. Two researchers independently screened articles, extracted data and assessed guideline quality using the Appraisal of Guidelines for Research and Evaluation version II. Thirty-one guidelines and consensus statements were included. Quality was high for 'clarity of presentation' (77%) and 'scope and purpose' (73%), moderate for 'stakeholder development' (56%), 'rigour of development' (48%) and 'editorial independence' (47%), and low for 'applicability' (29%). Two guidelines, related to physical activity and exercise, mindfulness, smoking cessation, and vitamin D and polyunsaturated fatty acid supplementation, scored high in all domains. These guidelines were two of only four guidelines intended for use by people with MS. High-quality guidelines and consensus statements to guide lifestyle modifications and complementary therapies in MS management are limited. Our findings indicate the need for more guidelines intended for use by people with MS, and a further focus on implementation resources.<br /> (© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
Published Date